AesMed Signs Exclusive Distribution Agreement in Azerbaijan

AesMed Signs Exclusive Distribution Agreement in Azerbaijan

Seoul, August 2025 – AesMed is pleased to announce that it has officially signed an Exclusive Distribution Agreement in the Republic of Azerbaijan, marking another important step in the company’s global expansion strategy.

This agreement strengthens AesMed’s position as a leading provider of advanced solutions for alopecia treatment and scalp care.
By securing exclusive distribution rights in Azerbaijan, AesMed is broadening access to its innovative therapies and professional-grade products in a market where awareness of hair loss solutions is rapidly increasing.

Azerbaijan represents a strategic region in AesMed’s international growth plan, connecting Europe and Asia and offering significant opportunities to expand high-quality hair care treatments. Through this agreement, local clinics and medical professionals will be able to provide patients with access to AesMed’s scientifically proven therapies, including the company’s flagship AGF39™ cytokine-based mesotherapy solution and its 4th Generation Advance Follicle Shampoos.

Looking ahead, this partnership is expected to create a foundation for broader collaboration in the region, while also contributing to AesMed’s global initiatives such as the Hair Care Day 2025 Campaign.

“AesMed is committed to delivering innovative, safe, and effective solutions for patients worldwide. The signing of this agreement in Azerbaijan reflects our mission to expand access to advanced alopecia treatments and to build strong international partnerships for the future,” Mr.Lee, CEO stated.

With this milestone, AesMed reaffirms its long-term vision of becoming a global leader in alopecia care, combining medical expertise, sustainable product innovation, and international cooperation.